Module I - Health Economic and Outcomes Research
-
Introduction to Health-economics and Outcomes Research
-
Cost Estimation of New Healthcare Technologies
-
ICER and its Application in Health Economic Evaluations
-
Heath-Related Quality of Life (HRQOL) Measures
-
Discounting in Health Economic Evaluation
-
Utility Measures Evaluation
-
Transferability of Cost Effectiveness Data Between Countries
-
Economic Evaluation in Clinical Trials
-
Importance of Economic Evaluation in Healthcare Industry
-
Pharmacoeconomic Guidelines for Health Care Decision Making
Module II - Health Technology Assessment and Real World Evidence
-
Introduction to Health Technology Assessment
-
Scope and Sources of Real World Evidence
-
Comparative Effectiveness Research
-
Retrospective Studies
-
Observational Studies in Healthcare Decision Making
-
Big Data Application in Real World Evidence
-
HEOR Principles in Real World Clinical Practice
-
Understanding Bias in Research
-
Guidelines and Regulatory Perspectives Around RWE
-
Scope of RWE in Healthcare Decision Making
Module III - Patient Reported Outcomes
-
Introduction to Patient-Reported Outcomes (PROs)
-
Item Response Theory
-
Content Validity of PRO, ClinRO and ObsRO Assessments
-
Psychometric Methods in PRO Assessment
-
Content Validity of PRO Instruments
-
Patient Preference Methods
-
PRO Analysis in Clinical Trials
-
PRO Evaluation as Part of Label Claims
-
Application of PRO Strategies in Early Clinical Product Development
-
Patient Centeredness and PROs in Healthcare Decision Making
Module IV - Modeling and Simulation
-
Introduction to Health Economic Modeling
-
Conceptual Health Economic Model Development
-
Types of Modeling Methods in Pharmacoeconomic Evaluation
-
Decision Tree Modeling and Analysis
-
Markov Modeling
-
Discrete Event Simulation (DES)
-
Bayesian Analysis
-
Health State Utilities and their Estimates for Economic Models
-
Budget Impact Analysis
-
Data Visualization and its Role in Healthcare Decision Making
Module V - Market Access, Pricing and Reimbursement
-
Healthcare Pricing: Pharmaceutical, Biotech and Medical Device
-
Reimbursement Systems and Methodologies
-
Future of Healthcare Reimbursement Methodologies
-
Multiple Criteria Decision Analysis (MCDA)
-
Patient Access Schemes for Drugs & Medical Devices
-
Formulary Development
-
Value Assessment Frameworks
-
Value-Based Pricing
-
Patients as Partners in Research and Drug Access
-
Evidence Needs in Healthcare Decision Making
